# SAJAZIR

NDC: 70709-013
Generic name: ICATIBANT
Labeler / Manufacturer: Cycle Pharmaceuticals Ltd-Uk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20210603

FDA application: ANDA212446

## Active ingredients

- ICATIBANT ACETATE: 30 mg/3mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70709-013"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70709-013
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1756aca0-21a1-4898-8d6c-9666738db45c